Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2017 (2017), Article ID 1478625, 11 pages
https://doi.org/10.1155/2017/1478625
Research Article

Lycopene Inhibits Propagation of Chlamydia Infection

1Gamaleya Center of Epidemiology and Microbiology, Ministry of Health, Moscow, Russia
2Lycotec Ltd., Granta Park Campus, Cambridge CB21 6GP, UK

Correspondence should be addressed to Ivan M. Petyaev

Received 14 February 2017; Accepted 11 June 2017; Published 29 August 2017

Academic Editor: Roland Bitsch

Copyright © 2017 Naylia A. Zigangirova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Price, A. E. Ades, K. Soldan et al., “The natural history of chlamydia trachomatis infection in women: A multi-parameter evidence synthesis,” Health Technology Assessment, vol. 20, no. 22, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Budzyński, J. Wiśniewska, M. Ciecierski, and A. Kedzia, “Association between Bacterial Infection and Peripheral Vascular Disease: A Review,” International Journal of Angiology, vol. 25, no. 1, Article ID 140130, pp. 3–13, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. I. M. Petyaev, N. A. Zigangirova, L. N. Kapotina, E. D. Fedina, and N. H. Kyle, “Chlamydia trachomatis promotes 3T3 cell differentiation into adipocytes,” Advances in Clinical and Experimental Medicine, vol. 23, no. 4, pp. 511–516, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Derré, “Chlamydiae interaction with the endoplasmic reticulum: Contact, function and consequences,” Cellular Microbiology, vol. 17, no. 7, pp. 959–966, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Nunes and J. P. Gomes, “Evolution, phylogeny, and molecular epidemiology of Chlamydia,” Infection, Genetics and Evolution, vol. 23, pp. 49–64, 2014. View at Publisher · View at Google Scholar
  6. N. Käding, M. Szaszák, and J. Rupp, “Imaging of Chlamydia and host cell metabolism,” Future Microbiology, vol. 9, no. 4, pp. 509–521, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. H. D. Caldwell, J. Kromhout, and J. Schachter, “Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis,” Infection and Immunity, vol. 31, no. 3, pp. 1161–1176, 1981. View at Google Scholar · View at Scopus
  8. Y. K. Bashmakov, N. A. Zigangirova, Y. P. Pashko, L. N. Kapotina, and I. M. Petyaev, “Chlamydia trachomatis growth inhibition and restoration of LDL-receptor level in HepG2 cells treated with mevastatin,” Comparative Hepatology, vol. 9, article no. 3, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Principi and S. Esposito, “Biomarkers in pediatric community-acquired pneumonia,” International Journal of Molecular Sciences, vol. 18, no. 2, article no. 447, 2017. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Smith and M. P. Angarone, “Sexually Transmitted Infections,” Urologic Clinics of North America, vol. 42, no. 4, pp. 507–518, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. F. J. Nieto, A. R. Folsom, P. D. Sorlie, J. T. Grayston, S.-P. Wang, and L. E. Chambless, “Chlamydia pneumoniae infection and incident coronary heart disease. The atherosclerosis risk in communities study,” American Journal of Epidemiology, vol. 150, no. 2, pp. 149–156, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. W. P. Koh, M. B. Taylor, K. Hughes et al., “Seroprevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in Singapore,” International Journal of Epidemiology, vol. 31, no. 5, pp. 1001–1007, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. M. S. Player, A. G. Mainous, C. J. Everett, V. A. Diaz, M. E. Knoll, and R. U. Wright, “Chlamydia pneumoniae and progression of subclinical atherosclerosis,” European Journal of Preventive Cardiology, vol. 21, no. 5, pp. 559–565, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Boman, S. Söderberg, J. Forsberg et al., “High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors,” Journal of Infectious Diseases, vol. 178, no. 1, pp. 274–277, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Krupp and P. Madhivanan, “Antibiotic resistance in prevalent bacterial and protozoan sexually transmitted infections,” Indian Journal of Sexually Transmitted Diseases, vol. 36, no. 1, pp. 3–8, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Barbieri, E. Coppo, A. Marchese et al., “Phytochemicals for human disease: An update on plant-derived compounds antibacterial activity,” Microbiological Research, vol. 196, pp. 44–68, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Törmäkangas, P. Vuorela, E. Saario, M. Leinonen, P. Saikku, and H. Vuorela, “In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model,” Biochemical Pharmacology, vol. 70, no. 8, pp. 1222–1230, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Erkkilä, M. Jauhiainen, K. Laitinen et al., “Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 9, pp. 3959–3962, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A. L. Lucas, S. P. Ouellette, E. J. Kabeiseman, K. H. Cichos, and E. A. Rucks, “The trans-Golgi SNARE syntaxin 10 is required for optimal development of Chlamydia trachomatis,” Frontiers in Cellular and Infection Microbiology, vol. 5, article no. 68, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Tiirola, M. Jauhiainen, L. Erkkilä et al., “Effect of pravastatin treatment on Chlamydia pneumoniae infection, inflammation and serum lipids in NIH/S mice,” International Journal of Antimicrobial Agents, vol. 29, no. 6, pp. 741-742, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. I. M. Petyaev, N. A. Zigangirova, A. M. Petyaev et al., “Isolation of Chlamydia pneumoniae from serum samples of the patients with acute coronary syndrome,” International Journal of Medical Sciences, vol. 7, no. 4, pp. 181–190, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. M. S. Rezaee-Zavareh, M. Tohidi, A. Sabouri, M. Ramezani-Binabaj, M. Sadeghi-Ghahrodi, and B. Einollahi, “Infectious and coronary artery disease,” ARYA Atherosclerosis, vol. 12, no. 1, pp. 41–49, 2016. View at Google Scholar · View at Scopus
  23. N. Torres, M. Guevara-Cruz, L. A. Velázquez-Villegas, and A. R. Tovar, “Nutrition and Atherosclerosis,” Archives of Medical Research, vol. 46, no. 5, pp. 408–426, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. T. H. Rissanen, S. Voutilainen, K. Nyyssönen, R. Salonen, G. A. Kaplan, and J. T. Salonen, “Serum lycopene concentrations and carotid atherosclerosis: the kuopio ischaemic heart disease risk factor study,” American Journal of Clinical Nutrition, vol. 77, no. 1, pp. 133–138, 2003. View at Google Scholar · View at Scopus
  25. L. Kohlmeier, J. D. Kark, E. Gomez-Gracia et al., “Lycopene and myocardial infarction risk in the EURAMIC study,” American Journal of Epidemiology, vol. 146, no. 8, pp. 618–626, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Klipstein-Grobusch, L. J. Launer, J. M. Geleijnse, H. Boeing, A. Hofman, and J. C. M. Witteman, “Serum carotenoids and atherosclerosis: The Rotterdam Study,” Atherosclerosis, vol. 148, no. 1, pp. 49–56, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. B. K. Prusty, L. Böhme, B. Bergmann et al., “Imbalanced Oxidative Stress Causes Chlamydial Persistence during Non-Productive Human Herpes Virus Co-Infection,” PLoS ONE, vol. 7, no. 10, Article ID e47427, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Di Pietro, S. Filardo, F. De Santis, P. Mastromarino, and R. Sessa, “Chlamydia pneumoniae and oxidative stress in cardiovascular disease: state of the art and prevention strategies,” International Journal of Molecular Sciences, vol. 16, no. 1, pp. 724–735, 2015. View at Publisher · View at Google Scholar · View at Scopus